Hybrid Event
2021 Research Showcase
This year more than any other, itu2019s important to recognize the outstanding research contributions our students and trainees have shared with our college and the scientific community.
A letter from the Dean
u0022Itu2019s been a truly remarkable year for research in the UF College of Pharmacy, and 34th Annual Research Showcase offers a unique opportunity to celebrate all our achievements.u0022
Welcome to the University of Florida College of Pharmacy’s 34th Annual Research Showcase. This year more than any other, it’s important to recognize the outstanding research contributions our students and trainees have shared with our college and the scientific community. These young scientists have persevered through a worldwide pandemic and the two month closure of most research labs on campus. Despite these challenges, they have advanced science and pushed new discoveries that improve human health. In some cases, they’ve contributed to the growing body of literature and understanding of COVID-19.
Research Showcase was founded more than three decades ago to bring greater visibility to student and trainee research and promote collaboration amongst departments. While this year’s event will have a different look and feel, the spirit of our oral and poster competitions will continue in a hybrid format. The tradition of welcoming an accomplished scientist as our keynote speaker continues as well, as we welcome Kathy Giacomini, Ph.D., from the University of California San Francisco. Her research focuses on the role membrane transporters play in pharmacogenomics and drug response.
Congratulations to all our students and trainees presenting this week and a special thank you to the faculty and staff who have supported their efforts. It’s been a truly remarkable year for research in the UF College of Pharmacy, and 34th Annual Research Showcase offers a unique opportunity to celebrate all our achievements.
Dr. Julie Johnson, PharmD
Dean and Distinguished Professor
College of Pharmacy
University of Florida
KEYNOTE Address
Transporters in Precision Medicine: From Genomewide Association Studies to Functional Genomics
Kathleen M. Giacomini, Ph.D.
Kathy Giacomini, a professor in the School of Pharmacy at the University of California, San Francisco, is a leader in the field of membrane transporters with a focus on genetic polymorphisms. She cloned, characterized and discovered the endogenous role of the human xenobiotic transporter, OCT1 (SLC22A1), and recently de-orphaned SLC22A24, an anion exchanger that preferentially transports steroid glucuronide conjugates.
Together with others, she co-founded the International Transporter Consortium, which has published highly impactful papers informing regulatory policy. She is the Co-Principal Investigator of the UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation and President of the Pharmacogenomics Research Network. She has received numerous awards and is an elected member of the National Academy of Medicine.
u003cstrongu003eScheduleu003c/strongu003e of Events
Monday, April 12, 2021
Virtual Networking Lounge
8:00am – 8:30am
Poster Competition
Graduate Students: Cancer (8:30am – 10:30am)
Graduate Students: Pain & Addiction (9:30am- 12:00pm)
Graduate Students: Chronic Diseases (12:30pm – 3:00pm)
Graduate Students: Infectious Diseases (1:30pm – 4:00pm)
Graduate Students: Drug Metabolism, Interactions, & Outcomes (2:30pm – 5:00pm)
Tuesday, April 13, 2021
Virtual Networking Lounge
8:00am – 8:30am
Poster Competition
Postdoctoral Trainees & Residents (8:30am – 11:30am)
PharmD Students: Group A (8:00am – 9:30am)
PharmD Students: Group B (9:00am – 10:30am)
PharmD Students: Group C (10:00am – 11:30am)
Undergraduate Students (10:00am – 11:30am)
Oral Presentation Competition
12:30pm – 3:30pm
Virtual Networking Lounge
3:30pm – 4:00pm
Keynote Speaker
4:00pm – 5:00pm
Awards Presentation
5:00pm
Poster Competition
Judges
| Category | Name | Department |
|---|---|---|
| Grad: Chronic Diseases | Jenny Wei | Pharmaceutical Outcomes & Policy |
| Grad: Chronic Diseases | Brandon Warren | Pharmacodynamics |
| Grad: Chronic Diseases | Caitrin McDonough | Pharmacotherapy & Translational Research |
| Grad: Infectious diseases | Yan Gong | Pharmacotherapy & Translational Research |
| Grad: Infectious diseases | Rodrigo Cristofoletti | Pharmaceutics |
| Grad: Infectious Diseases | Jenny Wilkerson | Pharmacodynamics |
| Grad: Drug Metabolism, Interactions, & Outcomes | Jingchuan Serena Guo | Pharmaceutical Outcomes & Policy |
| Grad: Drug Metabolism, Interactions, & Outcomes | Marco Mottinelli | Medicinal Chemistry |
| Grad: Drug Metabolism, Interactions, & Outcomes | Jatinder Lamba | Pharmacotherapy & Translational Research |
| Grad: Cancer | Yousong Ding | Medicinal Chemistry |
| Grad: Cancer | Takato Hiranita | Pharmacodynamics |
| Grad: Cancer | Fan Zhang | Pharmaceutics |
| Grad: Pain & Addiction | Aimie Goodin | Pharmaceutical Outcomes & Policy |
| Grad: Pain & Addiction | Will de Lartigue | Pharmacodynamics |
| Grad: Pain & Addiction | John Markowitz | Pharmacotherapy & Translational Research |
| PostDoc Trainees & Residents | Chris McCurdy | Medicinal Chemistry |
| PostDoc Trainees & Residents | Lance McMahon | Pharmacodynamics |
| PostDoc Trainees & Residents | Larisa Cavallari | Pharmacotherapy & Translational Research |
| Undergraduate Students | Chris Xing | Medicinal Chemistry |
| Undergraduate Students | Joanna Peris | Pharmacodynamics |
| Undergraduate Students | Abhisheak Sharma | Pharmaceutics |
| PharmD A | Rich Segal | Pharmaceutical Outcomes & Policy |
| PharmD A | Margaret James | Medicinal Chemistry |
| PharmD A | Cary Mobley | Pharmaceutics |
| PharmD B | Hui Shao | Pharmaceutical Outcomes & Policy |
| PharmD B | Emily Cicali | Pharmacotherapy & Translational Research |
| PharmD B | Sarah Kim | Pharmaceutics |
| PharmD C | Laura Happe | Pharmaceutical Outcomes & Policy |
| PharmD C | Gustavo de Miranda Seabra | Medicinal Chemistry |
| PharmD C | Jinmai Jiang | Pharmaceutics |
Sponsors
Ibrahim Dawwas Award for Cancer Research
Sponsored by Dr. Ghadeer Dawwas
Pain, Addiction and CNS Disorders Research Award
Sponsored by Dr. David Wallace
PharmD Research
Sponsored by Dr. John Markowitz
Linden Jovu00e9 Family Chronic Disease Award
Sponsored by Linden Jovué Family (Dr. Stephan Linden, ’13)
Generous Support of Poster Awards
Dr. Fatma Al-Awadhi ’17, Dr. Xinyue Liu ’15, Dr. Fuxing Tang ’00, Dr. Janice Cacace ’91, and Dr. Navin Goyal ’09 for their generous support of the showcase.
Submissions
| Primary Author | Additional Authors | Title of Research |
|---|---|---|
| Jessica Mamallapalli | J. Botello; C. Xing | Kava inhibits norepinephrine-induced cAMP production in lung cancer cells |
| Yuma Ortiz | J. Wilkerson; L. McMahon | Mitragynine reverses paclitaxel chemotherapy-induced peripheral neuropathy |
| Richard Marrero | A. Elsayed; N. Nguyen; X. Cao; H. Wu; S. Raimondi; R. Riberio; J. Rubnitz; S. Pounds; J. Lamba | Association of genetic polymorphisms in SAMHD1 gene on clinical outcomes in AML |
| Zachary Rabinowitz | L. Cui | Development of bioavailable substrate-based probes for PARP-1 |
| Sebastian Jugl | C. Chang; Y. Wang; J. Brown | Real-world patterns of CDK4/6 inhibitor associated interstitial-lung disease |
| Jing Pei | D. Lyu; Y. Xiao; G. Zheng; D. Zhou | Explore the potential of piperlongumine (PL) as a new E3 ligase ligand |
| Nam Nguyen | H. Wu; J. Ping; J. Rubnitz; S. Pounds; J. Lamba | Leukemic cell proteomic profiling in pediatric AML: a pilot study |
| Kelton Schleyer | J. Liu; Z. Wang; B. Fetrow; P. Fatland; A. Rollins; V. Wajsbrot; H. Guo; L. Cui | Expanding the toolkit of small molecule imaging probes for heparanase |
| Noor Nahid | E. Cicali; C. McDonough; Y. Gong; J. Johnson | Impact of CYP2D6 inhibitors on opioid therapy in patients with pain |
| Ching-Yuan Chang | J. Hincapie-Castillo; D. Wilson; W. Lo-Ciganic | Trends and characteristics of concurrent opioid use with high-risk medications |
| Mallory Burns | S. Intagliata; R. Rogers; S. Kamble; J. Cano; T. Kawesa; B. Avery; L. Toll; C. McCurdy | SAR and SMR investigation of thiol-Linker containing Sigma Receptor ligands |
| Julio Zuarth-Gonzalez | A. Patel; R. Patel; M. Patel; L. Gamez-Jimenez; N. Ho; F. Leon; M. Mottinelli; C. McCurdy; L. McMahon; T. Hiranita. | Mitragynine attenuates the development of morphine tolerance and withdrawal |
| Bo Sortman | C. Gobin; B. Warren | Cocaine seeking is mediated by Fos-expressing ensembles formed during acquisition |
| Ariana Brice-Tutt | S. Eans; D. Yakovlev; T. Yakovleva; J. Aldrich; J. McLaughlin | Development of a kappa opioid receptor antagonist to treat opioid use disorder |
| Amy Alleyne | L. Wilson; S. Harden; C. McCurdy; C. Frazier; J. McLaughlin | Sigma-1 ligands modulate methamphetamine sensitization and reward circuitry |
| Erin Berthold | S. Kamble; M. Kuntz; S. Kanumuri; T. King; B; Shaikoski; A; Sharma; C. McCurdy | Comparative pharmockinetic study of cannabidiol formulations |
| Ariana Figueroa | P. Zhang; A. Alleyne; S. Eans; T. Cirino; J. McLaughlin; S. Stevens; B. Liu | Effect of peripheral inflammation on microglial phenotypes: impact of SPP1 KO |
| Todd Sahagian | J. Thinschmidt; S. Harden; E. Krause; J. Peris, C. Frazier | Oxytocinergic modulation of VTA --> NAc reward circuitry |
| Morgan Crowley | S. Obeng; V. Pallares; F. Leon; L. Gamez-Jimenez; T. Hiranita; L. McMahon; C. McCurdy | Pharmacological comparison of a synthetic analog of a mitragyna speciosa alkaloid |
| Yun Shen | A. Goodin; J. Brown | Prescribing measures and medical marijuana physician authorization status in FL |
| Yahan Zhang | J. Bian; J. Huo; S. Yang; Y. Guo; H. Shao | Downstream costs and healthcare utilization of LDCT screening in ADRD patients |
| Piaopiao Li | R. Patel; S. Vouri; L. Shi; V. Fonseca; H. Shao | The diminishing cost-effectiveness of newer glucose-lowering drug classes in U.S. |
| Zachary Greenberg | M. He | Deep learning directed functionalization of exosomes for precision therapeutics |
| Earl Morris | N. Tokatly; C. Tortor; S. Vouri | Statin initiation for secondary prevention of ASCVD events in older adults |
| Shaimaa Elbalkiny | R. Frye; Y.Gong | Association of CES1 and FXR SNPs with susceptibility to NAFLD and NASH in the UKB |
| Golnoosh Alipour-Haris | L. Galiano; C. Hernandez; C.A. Leeflang; Z. Shultz; T. Muir; J. Brown | Medication regimen complexity and deprescribing in Alzheimer and related dementia |
| Jesus Penaloza Aponte | S. Eikenberry; J. Smith; A. de Kloet; E. Krause; K. Scott | Automated pipeline for analysis of social behavior and neuronal activity in mice |
| Christelle Lteif | R. Sharma; J. Duarte | Mirabegron improves RVSP in a pre-clinical model of PH-HFpEF |
| Aimalohi Okpeku | A. Goodin | Impact of mental health on readmissions among persons living with HIV |
| Shu Huang | W. Lo-Ciganic; H. Shao | Cost-effectiveness of intensive vs. moderate hypertension treatment in US adults |
| Mingxin Yang | M. Yang; G. de Lartigue | The role of nutrient-sensing hippocampal neurons in feeding |
| Jordan Howard | T. Sahagian; W. Sheng; S. Harden; J. Thinschmidt; C. Frazier | Cellular neurophysiology of OTR activation in the rat ventral subiculum |
| Elham Amini | S. Berger; J. Bulitta; G. Hochhaus | Can pharmacokinetics assess the local bioequivalence of suspension nasal sprays? |
| Ikenna Unigwe | S. Yang; H. Song; W. Lo-Ciganic; R. Cook; H. Park | Trends of STD in the United States ambulatory care clinics from 2005-2016 |
| Jieqiang Zhou | Y. Lang; T. Kim; X. Tao; A. Sayed; E. Shin; C. Werkman; A. Louie; G. Drusano; C. Landersdorfer; J. Bulitta | Characterizing thermal stability of β-lactam antibiotics in broth, agar and water |
| Dake Liu | T. Wanniarachchi; S. Bruner; Y. Ding | Novel metabolism of 5-nitroimidazole antibiotics by a pathogen nitroreductase |
| Chaejin Kim | J. Barrett; R. Lowenthal; S. Tanimoto; S. Schmidt; V. Vozmediano | Development of a physiologically based nasal absorption model and its application |
| Evelyn Franco | K. Hanrahan; A. Brown | Favipiravir inhibits Zika virus in HeLa cells by modulating viral infectivity |
| Lobna Elsadek | J. Matthews; S. Nishimura; T. Nakatani; A. Ito; T. Gu; D. Luo; L. Salvador-Reyes; V. Paul; H. Kakeya; H. Luesch | Genomic and targeted approaches unveil targets of an antifungal natural product |
| Eunjeong Shin | N. Shah; J. Oyer; A. Sayed; D. Sutaria; X. Tao; Y. Lang; J. Zhou; C. Werkman; A. Copik; J. Bulitta | Synergistic killing of Klebsiella pneumoniae by double β-lactams combinations |
| Simon Berger | E. Amini; J. Bulitta; G. Hochhaus | Alternative regulatory pathway for generic approval of nasal suspensions |
| Carolin Werkman | N. Shah; D. Lucas; J. Oyer; M. Megroz; A. Sayed; B. Moya; A. Wright; D. Sutaria; X. Tao; Y. Lang; J. Zhou; E. Shin; R. Jiminez-Nieves; K. Cadet; A. Copik; J. Boyce; J. Bulitta | Synergistic killing of acinetobacter baumannii via penicillin-binding proteins |
| Garret Rubin | Y. Zhang; K. Patel; M. Guo; A. Ishee; S. Bruner; Y. Ding | New enzymology in the biosynthesis of anti-protease tricyclic peptides |
| Dawei Guan | H. Shao | Trends of insulin price across different health insurance plans |
| Shailina Keshwani | I. Grande; M. Maguire; A. Goodin; S. Vouri; J. Hincapie-Castillo | Trends in utilization of prescription NSAIDs following Florida’s HB21 law |
| Raj Desai | S. Smith | Accuracy of developing new user cohorts using electronic health records data |
| Seonkyeong Yang | A. Lipe; M. Boren; J. Hincapie-Castillo; J. Brown; J. Guo; H. Park; C. Chang; D. Wilson; L. Adkins; W. Lo-Ciganic | Trends in the management of headache in US emergency departments: 2007-2018 |
| Amir Sarayani | J. Brown; S. Schmidt; A.. Winterstein | Does CYP3A4 induction by topiramate undermine oral contraceptive effectiveness? |
| Yuli Qian | J. Markowitz | Pharmacokinetic interactions between methylphenidate and cannabinoids |
| Brianna Costales | R. Matthews; J. Brown; A. Goodin | A pharmacovigilance analysis of restless legs syndrome treatments and suicidality |
| Brandon Klee | P. Melchert; Y. Qian; C. Galloway; J. Markowitz | Investigating the pharmacogenomics of ADHD in youth treated with methylphendate |
| Phuong Tran | P. Antonelli; A. Winterstein | Quinolone ear drops linked to tendinopathy and tendon rupture |
| Nicole Smolinski | P. Antonelli; A. Winterstein | Trends in the diagnosis and treatment of pediatric acute otitis media |
| Brian Cicali | K. Lingineni; R. Cristofoletti; T. Wendl; J. Hoechel; H. Wiesinger; A. Chaturvedula; V. Vozmediano; S. Schmidt | Levonorgestrel DDI studies in healthy and obese women using PBPK modeling |
| Tengfei Bian | Y. Wang; J. Botello; Q. Hu; Y. Jiang; A. Zingone; P. Corral; F. Aly; Y. Wu; B. Ryan; L. Jin; C. Xing | NNAL promotes lung cancer progression in an isomer-dependent manner |
| Xiaoshu Pan | P. Huang; N. Fernandez; Z. Greenberg; H. Staecker; M. He | CRISPR-Exosome nanoassembles for precise genetic correction in hearing loss |
| Dinesh Thummuri | S. Khan; P. Underwood; X. Zhang; P. Zheng; V. Budamagunta; A. Sobh; A. Tagmount; A. Loguinov; E. Williamson; J. Wiegand; R. Hromas; C. Vulpe; G. Zheng; J. Trevino; D. Zhou. | BCL-XL PROTAC-Gemcitabine combination as a potent therapy for pancreatic cancer |
| Marwa Tantawy | M. Chekka; T. Garrett; S. Singh; C. Shah; M. Fradley; R. Cornell; R. Baz; N. Waheed; D. DeRemer; L. Yuan; T. Langaee; K. March; C. Pepine; J. Moreb; Y. Gong | Lactate dehydrogenase B associated with carfilzomib relate cardiotoxicity |
| Juan Morales | J. Podichetty; J. Burton; N. Hanan; M. Thomas; K. Lingineni; P. Lang; S. David; F. Martin; M. Atkinson; M. Haller; K. Romero; I. O'Doherty; S. Schmidt; S. Kim | Quantifying heterogeneity contributing to risk of type 1 diabetes diagnosis |
| Khalid Elsaafien | M. Kirchner; M. Mohammed; S. Eikenberry; C. West; K. Scott; A. de Kloet; J. Stern; E. Krause | Angiotensin signaling in the paraventricular nucelus elevates blood pressure |
| Vivek Shastri | A. Elsayed; L. Chauhan; T. Alonzo; Y. Wang; R. Aplenc; B. Hirsch; A. Gamis; S. Meshinchi; J. Lamba | DDR-4-SNP score predicts GO response in AML patients: a pathway-directed analysis |
| Kimberly Atkinson | K. Vogel Anderson; M. Lo | Pharmacists increase access to diabetes supplies in an outpatient clinic setting |
| Tao Long | R.Cristofoletti; V. Michaud; P. Dow; J. Turgeon; S. Schmidt | PBPK modeling to assess CYP2D6-mediated DDI on tramadol and metabolite exposures |
| Michelle Pressly | S. Schmidt | Agent-based approach to understanding bone remodeling in osteoporosis |
| Laura Hanold | A. Cheek; J. Aldrich | The peptide [D-Trp]CJ-15,208 regulates proteins in the c-Myc degradation pathway |
| Yuzhi Wang | T. Bian; L. Jin; C. Xing | Nicotine exposure induces resistance to chemotherapy in small cell lung cancer |
| Yinzhi Lang | J. Zhou; N. Smith; X. Tao; A. Sayed; E. Shin; W. Carolin; R. Cha; B. Tsuji; J. Bulitta | Outer membrane (OM) permeability of six β-lactams in New Delhi metallo-β-lactamas |
| Hamed Kianmehr | J. Guo; J. Luo; L. Shi; V. Fonseca; H. Shao | To examine patient characteristics on incident congestive heart failure (CHF) |
| Julia Lessing | J. Boyle-Taylor; L. Dupree; A. Casapao | Competent vs. developing abstract skills: does past writing experience matter? |
| Kylie Paul | K. O'Mara; D. de la Cruz; K. Kisilewicz | Comparative outcomes of Intralipid to SMOFlipid in extremely premature neonates |
| Savine Hernandez | V. Venugopalan; K. DeSear; B. Santevecchi; J. Ashton; K. Cherabuddi; M. Alshaer; C. Peloquin; A. Casapao | Optimizing cefazolin dosing in the treatment of MSSA bacteremia |
| Erik Kienegger | B. Gonzalez; S. Berger; E. Amini; J. Bulitta; G. Hochhaus | Systematic evaluation of the ex-throat plume properties of MDI formulations |
| Andrew Garcia | T. Edminster; I. Molina; M. Muehlbauer | Immunomodulator therapy as salvage therapy to failing biologics in IBD patients |
| Nazifa Kadery | A. Ignacio; A. Tenpas; C. DeRemer | Evaluating the use of SGLT-2 inhibitors on weight change and microalbuminuria |
| Parminder Kaur | A. Carr; A. El Ghali; P. Kaur; S. Minor; A. Casapao | Early real-world evidence of eravacycline in draconian infections |
| Julie Al-Bahou | S. Vouri; H. Bhagwandass; I. Valdes; A. Alsuhibani | Changes in overactive bladder medication use before and after bariatric surgery |
| Blake Bartlett | M. Norris | Literature review of potential CYP2D6 inhibitors and their classifications |
| Matthew Muschett | J. Brown | Risk factors and costs associated with heart transplant readmissions in the U.S. |
| Megan Backus | A. Strahorn; S. Matys; A. Yathali; V. Grusauskas | Antidepressant prescribing patterns at a student-run free healthcare clinic |
| Christen Langley | A. Chizmar; S. Voils; A. Casapao | Perception vs reality: cross-sectional study of the 2020 pharmacy residency match |
| Jisoo Kim | N. Seligson; B. Duong; K. Blake; K. Cook | Pharmacogenomic medication use in pediatrics patients with sickle cell disease |
| Shivani Mehta | S. Mehta; E. Elwood; K. Vigal; G. Rosier; R. Rhoden; A. Williams; A. Cobb; P. Williams; F. Kaba; J. Alonso; E. Eddy; R. Copper-DeHoff | Genetic testing to understand and address renal disease disparities across the US |
| Natasha Emanuel | T. Larkin; A. Elsayed; R. Rafiee; B. Greer; B. Horn; J. Lamba | Identification of SNPs to optimize the treatment of acute childhood leukemia |
| Mahnoor Izhar | P. Molina; M. Thomas; E. Quesinberry; N. Seligson | Secondary genomic variants across fusion-driven sarcomas |
| Monica Bennett | S. Millis; D. Jin; N. Grosenbacher; C. Stets; J. Elvin; W. Miles; J. Hays; J. Chen; N. Seligson | Identifying predictors of loss of heterozygosity in leiomyosarcoma |
| Wendy Caba Piloto | E. Mougey; C. Gutiérrez-Junquera; S. Fernández-Fernández; M. Luz Cilleruelo; A. Rayo; B. Borrell; E. Román; C. González-Lois; M. Chao; H. Al-Atrash; J. Franciosi | TSLP/WDR36 variant associates with PPIREE |
| Erin Shepard | Y. Coll; S. Millis; J. Hays; J. Chen; N. Seligson | Alterations in histone H3 modifying henes in synovial sarcoma |
| Charles Verduzco | C. Lawrence; A. Phillips; T. Tran; D. Wang | Regulatory polymorphisms in CYP2D6 and their clinical implications |
| Breonna Harrison | R. Callender; J. Lamba; C. Ramos | Impact of gene associated methotrexate toxicity in acute lymphoblastic leukemia |
| Bradley Hall | N. Desai; A. Elchynski; Y. Marks; D. D'Silva; K. Nguyen | Utilizing a HCI approach to evaluate the design of current PGx-CDS |
| Connie Mei | Z. Gruen; L. Dumeny; L. Cavallari | Pharmacogenomics implementation in the arthroplasty setting |
| Orniel Caban | E. Alini; R. Glaubrecht; A. Parchment; N. Seligson | Prevalence of single cell transcriptomic heterogeneity in sarcoma |
| Danielle Pellett | L. Garayeva; P. Martinez-Quinones; J. Ngo; H. Fellows; J. Duarte | Clinical implementation of preemptive pharmacogenetic testing in the literature |
| Hanh Tran | L. Becirevic; N. Emanuel; M. Lofy; V. Shastri; J. Lamba | Ara-C SNP score to personalize cytarabine dosing: a retrospective study |
| Melissa Cuevas | J. Kelly; J. Lamba | Gene associated asparaginase hypersensitivity in pediatric ALL |
| Monique Hook | B. Dragoljevic; E. McKenna; A. Nguyen; D. Valentin; K. Nguyen; K. Wiisanen; L. Cavallari; A. Elchynski; E. Cicali | Evaluation of prescriber responses to TPMT pre-test alerts at UF Health |
| Joshua Bilbrey | Y. Ortiz; J. Felix; L. McMahon; J. Wilkerson | Evaluating effects of terpenoid compounds in mice with chronic neuropathic pain |
| Taylor Easey | J. Hincapie-Castillo; S. Vouri; A. Goodin | Impact of opioid acute pain limitation laws on opioid overdose deaths |
| Lismaury Galiano | C. Hernandez Zengotita; J. Brown; G. Alipour Haris | Review of medication regimen for patients with ADRD in sleep apnea guidelines. |
| Maryam Deravi | T. Tablante; L. Adkins; A. Goodin; J. Hincapie-Castillo | Systematic review of social media data sources for substance use trends |
| Sophie Bennett | E. Altamura; S. Bell; K. Cabrera; B. Zhang; C. Kim; V. Vozmediano | Review of nasal route for systemic and brain delivery: advantages and challenges |
| Natalie Ourhaan | H. Bhagwandass; A. Goodin; J. Hincapie-Castillo | Utilization trends of amphetamine-containing medications following law changes |
| Ivanna Grande | S. Keshwani; J. Hincapie-Castillo | Impact of opioid prescribing limits on NSAID use in state Medicaid programs |
| India Auchey | J. Brown | Cannabis use in pregnancy: a review of the literature |
| Avi Patel | S. Obeng; L Restrepo; L. Gamez-Jimenez; N. Ho; F. León; M. Mottinelli; C. McCurdy; L. McMahon; T. Hiranita | The primary kratom alkaloid mitragynine as an in vivo adrenergic-alpha2 receptor |
| Tychell Branchcomb | Y. Shen; H. Bhagwandass; S. Galvez; I. Grande; J. Lessing; M. Mollanazar; N. Ourhaan; R. Oueini; M. Sasser; I. Valdes; A. Jadubans; J. Hollmann; M. Maguire; S. Usmani; S. Vouri; J. Hincapie-Castillo; L. Adkins; A. Goodin | Chronic opioid therapy: a scoping literature review |
| Joyce Hernandez Maldonado | O. Grundmann | Non-HIV DDI's of artemisinin-based combination therapies in malaria treatment |
| Caroline Leeflang | J. Brown; G. Alipour Haris; C. Hernandez Zengotita | Psychiatric medication regimen complexity and eprescribing in ADRD |
| Shelby Luckey | A. Singh; G. de Lartigue | Bardet-Biedl syndrome 5 gene mutation promotes leptin resistance and obesity |
| Isadora Braga | A. Araujo; G. De Lartigue | Asymmetrical recruitment of vagal motor neurons by vagal sensory neurons |
| Katelyn Rourk | A. Singh; A. Bernier; G. de Lartigue | Can sweetened drinks impair metformin’s effect on glucose control in obese mice? |
| Alberto Jimenez Ybargollin | G. Zeng; W. Zhao; Z. Chen; X. Li; F. Liang; L. Cui | Epigenetic control of heparanase expression through CRISPR/dCas9 |
| Victoria Pallares | S. Obeng; M. Mottinelli; C. McCurdy; L. McMahon; T. Hiranita | In vitro pharmacological characterization of novel fentanyl analogs |
| Gabriel Leme | I. Braga; A. de Araujo; G. de Lartigue | Differential control of food intake by left and right vagal sensory neurons |
| Jane Hufnagel | S. Obeng; F. Leon; L. Restrepo; L. Gamez-Jimenez; A. Patel; N. Ho; T. Braun; J. Fortner; M. Crowley; V. Pallares; M. Mottinelli; C. Lopera-Londono; C. McCurdy; L. McMahon; T. Hiranita | Comparison of mu-opioid receptor activity of Kratom alkaloid and its metabolite |
Oral Competition
Judges
| Name | Department | |
|---|---|---|
| Lina Cui | Medicinal Chemistry | |
| Mei He | Pharmaceutics | |
| Juan Hincapie-Castillo | Pharmaceutical Outcomes & Policy | |
| Siobhan Malany | Pharmacodynamics | |
| Danxin Wang | Pharmacotherapy & Translational Research |
Sponsors
Oral Junior Competition Sponsored by
Dr. Maureen Keller-Wood
Oral senior Clinical Science Competition Sponsored by
Dr. Julie Johnson
Oral Millard Basic Science Competition Sponsored by
Dr. Meharvan Singh – BS ‘1989; PhD ’94
Postdoctoral Trainee Submissions
| Primary Author | Additional Authors | Title of Research |
|---|---|---|
| Hyerim Kang | W. Lo-Ciganic; C. DeRemer; E. Dietrich; P. Huang; H. Park | Effectiveness and safety of extended anticoagulation for venous thromboembolism |
| Sajid Khan | D. Thummuri; P. Kellish; N. Hua; P. Zhang; X. Zhang; J. Wiegand; G. Zheng; M. Zajac-Kaye; F. Kaye; D. Zhou | PROTAC-mediated BCL-XL degradation is an effective therapeutic strategy in SCLC |
| Arashdeep Singh | N. Haq; S. Luckey; S.Mansouri; H. Gogoi; M. Yang; K. Rourk; L. Jin; S. Christou-Savina; G. de Lartigue | Unravelling underlying mechanisms of Bardet-Biedl syndrome (BBS) phenotype |
Junior Competition Submissions
| Primary Author | Additional Authors | Title of Research |
|---|---|---|
| Mai Mehanna | C. McDonough; S. Smith; Y. Gong; J. Gums; J. Johnson; L. McIntyre; R. Cooper-DeHoff | Pharmacometabolomics reveals mechanisms underlying blood pressure response |
| Corey Perkins | J. Jiang; J. Bray; A. Gosling; L. da Silva; K. Rosenova Atanasova; R. Ratnayake; H. Hakimjavadi; S. Chamala; M. Campbell-Thompson; C. Li; H. Luesch; T. Schmittgen | Human pancreatic organoids to study the early events of pancreatic cancer |
| Cameron Thomas | A. Beitelshees; F. Franchi; M. Shahin; L. Kovar; Y. Gong; C. McDonough; J. Johnson; D. Angiolillo; L. Cavallari | A real-world investigation of the ABCD-GENE Score on cardiovascular outcomes. |
Senior: Basic Sciences Submissions
| Primary Author | Additional Authors | Title of Research |
|---|---|---|
| Manyun Chen | G. Rubin; G Jiang; Z. Raad; Y Ding | Biocatalytic synthesis of natural anti-UV agents |
| Qi Hu | P. Corral; S. Narayanapillai; P. Leitzman; P. Upadhyaya; M. O'Sullivan; SS. Hecht; J. Lu; C. Xing | Kava, dihydromethysticin and NNK-induced lung cancer: from lab animals to humans |
| Lisa Wilson | S. Eans; H. Agha; S. Intagliata; L. Toll; C. McCurdy; J. McLaughlin | Selective sigma receptor antagonists as novel treatments for chronic pain |
Senior: Clinical Sciences Submissions
| Primary Author | Additional Authors | Title of Research |
|---|---|---|
| Lakshmi Manasa Sakuntala Chekka | T. Langaee; D. Wang; R. Rolf; A. Chapman; J. Gums; R. Cooper-DeHoff; J. Johnson | Plasma microRNA profiling reveals potential biomarkers of thiazide response |
| Cheng Chen | A. Winterstein; W. Lo-Ciganic; P. Tighe; Y. Wei | Risk of fall associated with concomitant use of opioids and gabapentinoids |
| Mohammed Gbadamosi | V. Shastri; A. Elsayed; R. Rafiee; R. Ries; S. Meshinchi; J. Lamba | The CIDDR gene expression signature predicts response to gemtuzumab ozogamicin |
u003cstrongu003eThank Youu003c/strongu003e
Thank you to all of our sponsors and contributors to this year’s Research Showcase.